Cogent Biosciences (COGT) Receivables - Net (2017 - 2019)
Cogent Biosciences (COGT) posted quarterly Receivables - Net of $2.0 million for Q4 2019, up 19.9% year-over-year from $1.7 million in Q4 2018, and up 127.27% quarter-over-quarter from $880000.0 in Q3 2019.
Cogent Biosciences (COGT) Receivables - Net (2017 - 2019) Analysis & Trends
Cogent Biosciences (COGT) has reported Receivables - Net for 3 consecutive years, with $2.0 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Receivables - Net rose 19.9% year-over-year to $2.0 million; the TTM figure through Dec 2019 stood at $2.0 million (up 19.9% YoY), while the FY2019 annual figure was $2.0 million, up 19.9% from the prior year.
- Receivables - Net rose to $2.0 million in Q4 2019 per COGT's latest filing, from $880000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $2.0 million in Q1 2019 and bottomed at $830000.0 in Q4 2017.
- Historically, Receivables - Net has averaged $1.5 million across 3 years, with a median of $1.5 million in 2019.
- Annual changes were most pronounced in 2018 — Receivables - Net soared 100.96% — and 2019, when it slumped 37.98%.
- Cogent Biosciences' Receivables - Net stood at $830000.0 in 2017, then jumped by 100.96% to $1.7 million in 2018, then rose by 19.9% to $2.0 million in 2019.
- Business Quant data shows COGT's Receivables - Net at $2.0 million in Q4 2019, $880000.0 in Q3 2019, and $1.5 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2.00 Mn |
| Dec 31, 2019 | 2.00 Mn |
| Sep 30, 2019 | 880,000.00 |
| Sep 30, 2019 | 880,000.00 |
| Jun 30, 2019 | 1.49 Mn |
| Jun 30, 2019 | 1.49 Mn |
| Mar 31, 2019 | 2.04 Mn |
| Mar 31, 2019 | 2.04 Mn |
| Dec 31, 2018 | 1.67 Mn |
| Dec 31, 2018 | 1.67 Mn |
| Sep 30, 2018 | 1.42 Mn |
| Sep 30, 2018 | 1.42 Mn |
| Jun 30, 2018 | 1.20 Mn |
| Jun 30, 2018 | 1.20 Mn |
| Mar 31, 2018 | 1.60 Mn |
| Mar 31, 2018 | 1.60 Mn |
| Dec 31, 2017 | 830,000.00 |
| Dec 31, 2017 | 830,000.00 |